ACR Open Rheumatology (May 2024)

Home‐Based Telemedicine in Rheumatology—A Scoping Review

  • Swamy Venuturupalli,
  • Alexander Peck,
  • Yogamanas Jinka,
  • Natalie Fortune,
  • Nikhil Davuluri,
  • William B. Nowell,
  • Kelly Gavigan,
  • John Cush,
  • Neelkamal Soares,
  • Rebecca Grainger,
  • Jeffrey R. Curtis

DOI
https://doi.org/10.1002/acr2.11660
Journal volume & issue
Vol. 6, no. 5
pp. 312 – 320

Abstract

Read online

Objective We performed a scoping review of the relevant literature on home‐based telehealth in rheumatology to understand its appropriate application in rheumatology practice. Methods We searched the Cochrane Library, PubMed, Web of Science, and scientific meeting abstracts to identify articles that specifically addressed telehealth suitability, barriers to telehealth, patient‐reported outcomes (PROs) collected in telehealth settings, and telehealth satisfaction. From the initial search of 4,882 studies, 23 reports were included. In addition, 10 abstracts were also eligible for analysis, resulting in a total of 33 articles: 2 randomized clinical trials, 9 prospective cohort studies, and 22 retrospective studies. Results We found that triage appointments or predictive models could be helpful in selecting patients for telehealth and that telehealth interventions were appropriate for follow‐up of patients with systemic lupus erythematosus and inflammatory arthritis, but that conducting new patient visits over telehealth was not ideal. Barriers to telehealth include patient factors (age, technology access) and need for physician/process factors (eg, physical examinations). PROs collected in regular practice can be incorporated into telehealth. Several small, single‐center studies suggest that telehealth does not lead to negative outcomes compared with in‐person visits, and overall, patients report high patient satisfaction with telehealth. In several scenarios, home‐based telehealth was equivalent to in‐person visits with regard to patient outcomes and satisfaction. Conclusion The widespread potential of telehealth to manage and deliver care for people with rheumatic disease is significant. As such, further research in the form of randomized controlled trials can help contribute to growing evidence that shapes telehealth implementation for patients with rheumatic diseases.